노틸러스 바이오테크놀로지(NAUT)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.98 (+0.36%), 시가총액 $0.30B, 52주 최저~최고 $0.64 ~ $3.95.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In additi
노틸러스 바이오테크놀로지의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
노틸러스 바이오테크놀로지의 현재 주가는 $0.98 (+0.36%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
노틸러스 바이오테크놀로지의 시가총액은 약 $0.30B입니다.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. Th